Deferred Tax Assets, Valuation Allowance of Humacyte, Inc. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Humacyte, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
  • Humacyte, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $182,867,000, a 21% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Humacyte, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $182,867,000 +$31,190,000 +21% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $151,677,000 +$20,526,000 +16% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $131,151,000 +$19,576,000 +18% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $111,575,000 +$9,818,000 +9.6% 31 Dec 2021 10-K 24 Mar 2023 2022 FY
Q4 2020 $101,757,000 31 Dec 2020 10-K 29 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.